Home > Press Releases > Point-of-Care Diagnostics Market

Point-of-Care Diagnostics Market Likely to Surpass ~USD 35 billion by 2035

Report Code: HC-4694  |  Published in: Mar 2026, By MarketGenics  |  Number of pages: 321
Get PDF
Buy

Global Point-of-Care Diagnostics Market Forecast 2035:

According to the report, the global point-of-care diagnostics market is likely to grow from USD 16.3 Billion in 2025 to USD 35.3 Billion in 2035 at a highest CAGR of 8% during the time period. The global point‑of‑care diagnostics market is experiencing robust growth because of three main factors which include rising demand for immediate testing at patient locations and increased adoption of decentralized healthcare services and need for urgent medical assessments. Healthcare providers and patients adopt portable diagnostic devices which provide instant results to support patient monitoring and achieve better medical results.

Public health programs and government health initiatives lead to increased adoption of point‑of‑care tests which help screen infectious diseases and manage chronic diseases and monitor vaccination progress especially in developing countries. The combination of artificial intelligence (AI) technologies with cloud analytics and connected devices enables test processes to achieve better accuracy and enhanced predictive capabilities and immediate result delivery.

Hospitals and clinics and home healthcare services will benefit from point-of-care devices which combine wearable technology with mobile connectivity to provide doctors with persistent patient observation capabilities and remote patient data access. The combination of technological progress with accessible solutions which provide instant diagnostic results is driving worldwide expansion of point‑of‑care diagnostics systems.  

Key Driver, Restraint, and Growth Opportunity Shaping the Global Point-of-Care Diagnostics Market

The increasing acceptance of point-of-care testing from pharmacies, outpatient facilities, and telemedicine will continue to fuel the development of the global point-of-care diagnostics industry. The growing demand from patients for easy access to rapid testing for disease diagnosis, monitoring of chronic illnesses, and obtaining the necessary treatments in a timely manner is driving the use of point-of-care testing for more effective monitoring (e.g., blood glucose monitoring, cholesterol testing, and the diagnosis of infectious diseases).

Used correctly, point-of-care devices will also enable healthcare workers to improve both the effectiveness of their work (operational) and to enhance their engagement with patients.

One key focus for improving test accuracy and reliability is how to make sure tests can be done accurately and reliably in years or places where tests will be done such as the people's home and how the environment and people's behavior could affect how successful or as cost-effective as these tests can be used.

Therefore, one of the areas that have a great deal of potential to help achieve better point-of-care testing accuracy and reliability and ultimately achieving better overall health is to implement new types of POC diagnostic tests both at school systems and in the workplace.

This implementation of point-of-care testing into school and workplace health programs would allow schools and workplaces to effectively and accurately identify newly diagnosed contagious disease and provide their employees/students with routine health screening and promote preventive care by providing them with timely data on their tests and providing ongoing health assessments of their employee's or students' populations at no cost.

Expansion of Global Point-of-Care Diagnostics Market

Technological Innovation, Healthcare Integration, and Rising Chronic Disease Burden Driving the Global Point‑of‑Care Diagnostics Market Expansion

  • There has been an increase in the demand for point‑of‑care diagnostic testing than ever before, mostly because of technological advances, stronger ties to the healthcare system and the explosive growth of chronic diseases. Technology has developed into robust, portable, accurate, easy to use point of care diagnostic devices because of recent advancements in microfluidics, biosensors, miniaturization and connectivity.
  • Patients will be able to obtain test results at the point of care in real time and also send that information back to their provider or to their electronic health record in the near future. In addition, the integration of AI into point of care diagnostic tools combined with cloud-based analysis will improve the clinical diagnostic accuracy and provide predictive information to providers. Using both of these technologies will also facilitate the ability to remotely monitor patients.
  • Since, more and more individuals suffer from chronic conditions such as obesity, diabetes, heart disease and other infectious diseases, demand for point of care solutions that do not require a hospital/clinical setting is growing. The development of integrated technologies is already changing how we deliver healthcare and is currently propelling the growth of the point of care diagnostics market.
  • An example of this is multiple governments launching AI Diagnostic tools that are located at public hospitals to decrease the amount of time between a patient's visit and receiving the final result for their diagnosis.

Regional Analysis of Global Point-of-Care Diagnostics Market

  • North America is experiencing the largest demand for point-of-care diagnostics in the world because it has a mature healthcare system, a high number of people with chronic diseases and the best reimbursement systems found anywhere in the world. According to the Centers for Disease Control and Prevention, almost 60% of adults in America have chronic diseases such as diabetes and heart disease which creates a huge demand for ongoing monitoring and rapid testing.
  • Because nearly everyone in America has insurance, most often through Medicare, but also through commercial plans, the use of point-of-care tests products is likely to go up. There is also a large presence of diagnostic companies in North America and many of them are investing heavily in developing AI-based, connected point-of-care tests devices which will help to maintain North America’s dominant position in the point-of-care diagnostics market globally.
  • The largest growth rate in point-of-care diagnostics will occur in the Asia Pacific region. Healthcare in many parts of Asia is becoming increasingly digitized; people are becoming increasingly aware of the benefits of preventative care and there are many areas of rural and underserved people who do not have access to diagnostic testing.
  • Mobile applications to improve health, inexpensive point-of-care tests products, and government-led initiatives like India's National Health Mission program are allowing for the rapid distribution of diagnostic services to increasingly large populations. In addition, the continued partnership of local startups with global companies that provide healthcare technology is further accelerating the adoption of point-of-care tests products, putting the Asia Pacific region in the best position to be the fastest growing geographic region in the global point-of-care diagnostics market for many years to come.

Prominent players operating in global point-of-care diagnostics market include prominent companies such as Abbott Laboratories, Becton, Dickinson and Company, bioMérieux S.A., Bio-Rad Laboratories, Inc., Chembio Diagnostics, Inc., Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Nova Biomedical Corporation, OraSure Technologies, Inc., PTS Diagnostics, QIAGEN N.V., QuidelOrtho Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Trinity Biotech plc, Trividia Health, Inc., Werfen S.A., along with several other key players.

The global point-of-care diagnostics market has been segmented as follows:

Global Point-of-Care Diagnostics Market Analysis, by Product Type

  • Glucose Monitoring Products
    • Blood Glucose Meters
    • Continuous Glucose Monitoring Systems
    • Test Strips & Lancets
    • Others
  • Infectious Disease Testing Products
    • Rapid Antigen Tests
    • Molecular Diagnostic POC Tests
    • Antibody-based Tests
    • Others
  • Cardiometabolic Monitoring Products
    • Cholesterol Testing Kits
    • HbA1c Testing Devices
    • Lipid Profile Testing Devices
    • Others
  • Pregnancy & Fertility Testing Products
    • Pregnancy Test Kits
    • Ovulation Test Kits
    • Others
  • Coagulation Monitoring Products
    • Prothrombin Time Testing Devices
    • INR Monitoring Systems
    • Others
  • Blood Gas & Electrolyte Testing Products
  • Urinalysis Testing Products
  • Hematology Testing Products
  • Others

Global Point-of-Care Diagnostics Market Analysis, by Technology

  • Lateral Flow Assays
  • Immunoassays
  • Molecular Diagnostics
    • PCR-based Testing
    • Isothermal Nucleic Acid Amplification
    • Others
  • Biosensor-based Diagnostics
  • Microfluidics-based Diagnostics
  • Lab-on-a-Chip Technologies
  • Others

Global Point-of-Care Diagnostics Market Analysis, by Sample Type

  • Blood
  • Urine
  • Saliva
  • Nasal & Nasopharyngeal Swabs
  • Stool Samples
  • Other Body Fluids

Global Point-of-Care Diagnostics Market Analysis, by Application

  • Infectious Diseases
    • COVID-19
    • Influenza
    • HIV
    • Hepatitis
    • Tuberculosis
    • Others
  • Diabetes Management
  • Cardiovascular Diseases
  • Oncology
  • Respiratory Diseases
  • Pregnancy & Fertility Testing
  • Metabolic Disorders
  • Others

Global Point-of-Care Diagnostics Market Analysis, by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Ambulatory Care Centers
  • Physician Offices
  • Research Institutes
  • Others

Global Point-of-Care Diagnostics Market Analysis, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Direct Sales to Healthcare Facilities
  • Others

Global Point-of-Care Diagnostics Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Natures
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Natures
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Point-of-Care Diagnostics Market Outlook
      • 2.1.1. Point-of-Care Diagnostics Market Size (Value - US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising prevalence of chronic and infectious diseases driving demand for rapid, on-site diagnostics.
        • 4.1.1.2. Technological advancements, including AI-enabled, wearable, and connected diagnostic devices.
        • 4.1.1.3. Growing adoption of decentralized and home-based healthcare solutions.
      • 4.1.2. Restraints
        • 4.1.2.1. High cost and complexity of integrating POC devices with existing healthcare IT systems.
        • 4.1.2.2. Stringent regulatory requirements and lengthy approval processes for new diagnostic devices.
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Point-of-Care Diagnostics Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Point-of-Care Diagnostics Market Analysis, by Product Type
    • 6.1. Key Segment Analysis
    • 6.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
      • 6.2.1. Glucose Monitoring Products
        • 6.2.1.1. Blood Glucose Meters
        • 6.2.1.2. Continuous Glucose Monitoring Systems
        • 6.2.1.3. Test Strips & Lancets
        • 6.2.1.4. Others
      • 6.2.2. Infectious Disease Testing Products
        • 6.2.2.1. Rapid Antigen Tests
        • 6.2.2.2. Molecular Diagnostic POC Tests
        • 6.2.2.3. Antibody-based Tests
        • 6.2.2.4. Others
      • 6.2.3. Cardiometabolic Monitoring Products
        • 6.2.3.1. Cholesterol Testing Kits
        • 6.2.3.2. HbA1c Testing Devices
        • 6.2.3.3. Lipid Profile Testing Devices
        • 6.2.3.4. Others
      • 6.2.4. Pregnancy & Fertility Testing Products
        • 6.2.4.1. Pregnancy Test Kits
        • 6.2.4.2. Ovulation Test Kits
        • 6.2.4.3. Others
      • 6.2.5. Coagulation Monitoring Products
        • 6.2.5.1. Prothrombin Time Testing Devices
        • 6.2.5.2. INR Monitoring Systems
        • 6.2.5.3. Others
      • 6.2.6. Blood Gas & Electrolyte Testing Products
      • 6.2.7. Urinalysis Testing Products
      • 6.2.8. Hematology Testing Products
      • 6.2.9. Others
  • 7. Global Point-of-Care Diagnostics Market Analysis, by Technology
    • 7.1. Key Segment Analysis
    • 7.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 7.2.1. Lateral Flow Assays
      • 7.2.2. Immunoassays
      • 7.2.3. Molecular Diagnostics
        • 7.2.3.1. PCR-based Testing
        • 7.2.3.2. Isothermal Nucleic Acid Amplification
        • 7.2.3.3. Others
      • 7.2.4. Biosensor-based Diagnostics
      • 7.2.5. Microfluidics-based Diagnostics
      • 7.2.6. Lab-on-a-Chip Technologies
      • 7.2.7. Others
  • 8. Global Point-of-Care Diagnostics Market Analysis, by Sample Type
    • 8.1. Key Segment Analysis
    • 8.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Sample Type, 2021-2035
      • 8.2.1. Blood
      • 8.2.2. Urine
      • 8.2.3. Saliva
      • 8.2.4. Nasal & Nasopharyngeal Swabs
      • 8.2.5. Stool Samples
      • 8.2.6. Other Body Fluids
  • 9. Global Point-of-Care Diagnostics Market Analysis, by Application
    • 9.1. Key Segment Analysis
    • 9.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 9.2.1. Infectious Diseases
        • 9.2.1.1. COVID-19
        • 9.2.1.2. Influenza
        • 9.2.1.3. HIV
        • 9.2.1.4. Hepatitis
        • 9.2.1.5. Tuberculosis
        • 9.2.1.6. Others
      • 9.2.2. Diabetes Management
      • 9.2.3. Cardiovascular Diseases
      • 9.2.4. Oncology
      • 9.2.5. Respiratory Diseases
      • 9.2.6. Pregnancy & Fertility Testing
      • 9.2.7. Metabolic Disorders
      • 9.2.8. Others
  • 10. Global Point-of-Care Diagnostics Market Analysis, by End User
    • 10.1. Key Segment Analysis
    • 10.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
      • 10.2.1. Hospitals & Clinics
      • 10.2.2. Diagnostic Laboratories
      • 10.2.3. Home Care Settings
      • 10.2.4. Ambulatory Care Centers
      • 10.2.5. Physician Offices
      • 10.2.6. Research Institutes
      • 10.2.7. Others
  • 11. Global Point-of-Care Diagnostics Market Analysis, by Distribution Channel
    • 11.1. Key Segment Analysis
    • 11.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Distribution Channel, 2021-2035
      • 11.2.1. Hospital Pharmacies
      • 11.2.2. Retail Pharmacies
      • 11.2.3. Online Pharmacies
      • 11.2.4. Direct Sales to Healthcare Facilities
      • 11.2.5. Others
  • 12. Global Point-of-Care Diagnostics Market Analysis and Forecasts, by Region
    • 12.1. Key Findings
    • 12.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 12.2.1. North America
      • 12.2.2. Europe
      • 12.2.3. Asia Pacific
      • 12.2.4. Middle East
      • 12.2.5. Africa
      • 12.2.6. South America
  • 13. North America Point-of-Care Diagnostics Market Analysis
    • 13.1. Key Segment Analysis
    • 13.2. Regional Snapshot
    • 13.3. North America Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 13.3.1. Product Type
      • 13.3.2. Technology
      • 13.3.3. Sample Type
      • 13.3.4. Application
      • 13.3.5. End User
      • 13.3.6. Distribution Channel
      • 13.3.7. Country
        • 13.3.7.1. USA
        • 13.3.7.2. Canada
        • 13.3.7.3. Mexico
    • 13.4. USA Point-of-Care Diagnostics Market
      • 13.4.1. Country Segmental Analysis
      • 13.4.2. Product Type
      • 13.4.3. Technology
      • 13.4.4. Sample Type
      • 13.4.5. Application
      • 13.4.6. End User
      • 13.4.7. Distribution Channel
    • 13.5. Canada Point-of-Care Diagnostics Market
      • 13.5.1. Country Segmental Analysis
      • 13.5.2. Product Type
      • 13.5.3. Technology
      • 13.5.4. Sample Type
      • 13.5.5. Application
      • 13.5.6. End User
      • 13.5.7. Distribution Channel
    • 13.6. Mexico Point-of-Care Diagnostics Market
      • 13.6.1. Country Segmental Analysis
      • 13.6.2. Product Type
      • 13.6.3. Technology
      • 13.6.4. Sample Type
      • 13.6.5. Application
      • 13.6.6. End User
      • 13.6.7. Distribution Channel
  • 14. Europe Point-of-Care Diagnostics Market Analysis
    • 14.1. Key Segment Analysis
    • 14.2. Regional Snapshot
    • 14.3. Europe Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 14.3.1. Product Type
      • 14.3.2. Technology
      • 14.3.3. Sample Type
      • 14.3.4. Application
      • 14.3.5. End User
      • 14.3.6. Distribution Channel
      • 14.3.7. Country
        • 14.3.7.1. Germany
        • 14.3.7.2. United Kingdom
        • 14.3.7.3. France
        • 14.3.7.4. Italy
        • 14.3.7.5. Spain
        • 14.3.7.6. Netherlands
        • 14.3.7.7. Nordic Countries
        • 14.3.7.8. Poland
        • 14.3.7.9. Russia & CIS
        • 14.3.7.10. Rest of Europe
    • 14.4. Germany Point-of-Care Diagnostics Market
      • 14.4.1. Country Segmental Analysis
      • 14.4.2. Product Type
      • 14.4.3. Technology
      • 14.4.4. Sample Type
      • 14.4.5. Application
      • 14.4.6. End User
      • 14.4.7. Distribution Channel
    • 14.5. United Kingdom Point-of-Care Diagnostics Market
      • 14.5.1. Country Segmental Analysis
      • 14.5.2. Product Type
      • 14.5.3. Technology
      • 14.5.4. Sample Type
      • 14.5.5. Application
      • 14.5.6. End User
      • 14.5.7. Distribution Channel
    • 14.6. France Point-of-Care Diagnostics Market
      • 14.6.1. Country Segmental Analysis
      • 14.6.2. Product Type
      • 14.6.3. Technology
      • 14.6.4. Sample Type
      • 14.6.5. Application
      • 14.6.6. End User
      • 14.6.7. Distribution Channel
    • 14.7. Italy Point-of-Care Diagnostics Market
      • 14.7.1. Country Segmental Analysis
      • 14.7.2. Product Type
      • 14.7.3. Technology
      • 14.7.4. Sample Type
      • 14.7.5. Application
      • 14.7.6. End User
      • 14.7.7. Distribution Channel
    • 14.8. Spain Point-of-Care Diagnostics Market
      • 14.8.1. Country Segmental Analysis
      • 14.8.2. Product Type
      • 14.8.3. Technology
      • 14.8.4. Sample Type
      • 14.8.5. Application
      • 14.8.6. End User
      • 14.8.7. Distribution Channel
    • 14.9. Netherlands Point-of-Care Diagnostics Market
      • 14.9.1. Country Segmental Analysis
      • 14.9.2. Product Type
      • 14.9.3. Technology
      • 14.9.4. Sample Type
      • 14.9.5. Application
      • 14.9.6. End User
      • 14.9.7. Distribution Channel
    • 14.10. Nordic Countries Point-of-Care Diagnostics Market
      • 14.10.1. Country Segmental Analysis
      • 14.10.2. Product Type
      • 14.10.3. Technology
      • 14.10.4. Sample Type
      • 14.10.5. Application
      • 14.10.6. End User
      • 14.10.7. Distribution Channel
    • 14.11. Poland Point-of-Care Diagnostics Market
      • 14.11.1. Country Segmental Analysis
      • 14.11.2. Product Type
      • 14.11.3. Technology
      • 14.11.4. Sample Type
      • 14.11.5. Application
      • 14.11.6. End User
      • 14.11.7. Distribution Channel
    • 14.12. Russia & CIS Point-of-Care Diagnostics Market
      • 14.12.1. Country Segmental Analysis
      • 14.12.2. Product Type
      • 14.12.3. Technology
      • 14.12.4. Sample Type
      • 14.12.5. Application
      • 14.12.6. End User
      • 14.12.7. Distribution Channel
    • 14.13. Rest of Europe Point-of-Care Diagnostics Market
      • 14.13.1. Country Segmental Analysis
      • 14.13.2. Product Type
      • 14.13.3. Technology
      • 14.13.4. Sample Type
      • 14.13.5. Application
      • 14.13.6. End User
      • 14.13.7. Distribution Channel
  • 15. Asia Pacific Point-of-Care Diagnostics Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. Asia Pacific Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Product Type
      • 15.3.2. Technology
      • 15.3.3. Sample Type
      • 15.3.4. Application
      • 15.3.5. End User
      • 15.3.6. Distribution Channel
      • 15.3.7. Country
        • 15.3.7.1. China
        • 15.3.7.2. India
        • 15.3.7.3. Japan
        • 15.3.7.4. South Korea
        • 15.3.7.5. Australia and New Zealand
        • 15.3.7.6. Indonesia
        • 15.3.7.7. Malaysia
        • 15.3.7.8. Thailand
        • 15.3.7.9. Vietnam
        • 15.3.7.10. Rest of Asia Pacific
    • 15.4. China Point-of-Care Diagnostics Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Product Type
      • 15.4.3. Technology
      • 15.4.4. Sample Type
      • 15.4.5. Application
      • 15.4.6. End User
      • 15.4.7. Distribution Channel
    • 15.5. India Point-of-Care Diagnostics Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Product Type
      • 15.5.3. Technology
      • 15.5.4. Sample Type
      • 15.5.5. Application
      • 15.5.6. End User
      • 15.5.7. Distribution Channel
    • 15.6. Japan Point-of-Care Diagnostics Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Product Type
      • 15.6.3. Technology
      • 15.6.4. Sample Type
      • 15.6.5. Application
      • 15.6.6. End User
      • 15.6.7. Distribution Channel
    • 15.7. South Korea Point-of-Care Diagnostics Market
      • 15.7.1. Country Segmental Analysis
      • 15.7.2. Product Type
      • 15.7.3. Technology
      • 15.7.4. Sample Type
      • 15.7.5. Application
      • 15.7.6. End User
      • 15.7.7. Distribution Channel
    • 15.8. Australia and New Zealand Point-of-Care Diagnostics Market
      • 15.8.1. Country Segmental Analysis
      • 15.8.2. Product Type
      • 15.8.3. Technology
      • 15.8.4. Sample Type
      • 15.8.5. Application
      • 15.8.6. End User
      • 15.8.7. Distribution Channel
    • 15.9. Indonesia Point-of-Care Diagnostics Market
      • 15.9.1. Country Segmental Analysis
      • 15.9.2. Product Type
      • 15.9.3. Technology
      • 15.9.4. Sample Type
      • 15.9.5. Application
      • 15.9.6. End User
      • 15.9.7. Distribution Channel
    • 15.10. Malaysia Point-of-Care Diagnostics Market
      • 15.10.1. Country Segmental Analysis
      • 15.10.2. Product Type
      • 15.10.3. Technology
      • 15.10.4. Sample Type
      • 15.10.5. Application
      • 15.10.6. End User
      • 15.10.7. Distribution Channel
    • 15.11. Thailand Point-of-Care Diagnostics Market
      • 15.11.1. Country Segmental Analysis
      • 15.11.2. Product Type
      • 15.11.3. Technology
      • 15.11.4. Sample Type
      • 15.11.5. Application
      • 15.11.6. End User
      • 15.11.7. Distribution Channel
    • 15.12. Vietnam Point-of-Care Diagnostics Market
      • 15.12.1. Country Segmental Analysis
      • 15.12.2. Product Type
      • 15.12.3. Technology
      • 15.12.4. Sample Type
      • 15.12.5. Application
      • 15.12.6. End User
      • 15.12.7. Distribution Channel
    • 15.13. Rest of Asia Pacific Point-of-Care Diagnostics Market
      • 15.13.1. Country Segmental Analysis
      • 15.13.2. Product Type
      • 15.13.3. Technology
      • 15.13.4. Sample Type
      • 15.13.5. Application
      • 15.13.6. End User
      • 15.13.7. Distribution Channel
  • 16. Middle East Point-of-Care Diagnostics Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Middle East Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Product Type
      • 16.3.2. Technology
      • 16.3.3. Sample Type
      • 16.3.4. Application
      • 16.3.5. End User
      • 16.3.6. Distribution Channel
      • 16.3.7. Country
        • 16.3.7.1. Turkey
        • 16.3.7.2. UAE
        • 16.3.7.3. Saudi Arabia
        • 16.3.7.4. Israel
        • 16.3.7.5. Rest of Middle East
    • 16.4. Turkey Point-of-Care Diagnostics Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Product Type
      • 16.4.3. Technology
      • 16.4.4. Sample Type
      • 16.4.5. Application
      • 16.4.6. End User
      • 16.4.7. Distribution Channel
    • 16.5. UAE Point-of-Care Diagnostics Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Product Type
      • 16.5.3. Technology
      • 16.5.4. Sample Type
      • 16.5.5. Application
      • 16.5.6. End User
      • 16.5.7. Distribution Channel
    • 16.6. Saudi Arabia Point-of-Care Diagnostics Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Product Type
      • 16.6.3. Technology
      • 16.6.4. Sample Type
      • 16.6.5. Application
      • 16.6.6. End User
      • 16.6.7. Distribution Channel
    • 16.7. Israel Point-of-Care Diagnostics Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Product Type
      • 16.7.3. Technology
      • 16.7.4. Sample Type
      • 16.7.5. Application
      • 16.7.6. End User
      • 16.7.7. Distribution Channel
    • 16.8. Rest of Middle East Point-of-Care Diagnostics Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Product Type
      • 16.8.3. Technology
      • 16.8.4. Sample Type
      • 16.8.5. Application
      • 16.8.6. End User
      • 16.8.7. Distribution Channel
  • 17. Africa Point-of-Care Diagnostics Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Africa Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Product Type
      • 17.3.2. Technology
      • 17.3.3. Sample Type
      • 17.3.4. Application
      • 17.3.5. End User
      • 17.3.6. Distribution Channel
      • 17.3.7. Country
        • 17.3.7.1. South Africa
        • 17.3.7.2. Egypt
        • 17.3.7.3. Nigeria
        • 17.3.7.4. Algeria
        • 17.3.7.5. Rest of Africa
    • 17.4. South Africa Point-of-Care Diagnostics Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Product Type
      • 17.4.3. Technology
      • 17.4.4. Sample Type
      • 17.4.5. Application
      • 17.4.6. End User
      • 17.4.7. Distribution Channel
    • 17.5. Egypt Point-of-Care Diagnostics Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Product Type
      • 17.5.3. Technology
      • 17.5.4. Sample Type
      • 17.5.5. Application
      • 17.5.6. End User
      • 17.5.7. Distribution Channel
    • 17.6. Nigeria Point-of-Care Diagnostics Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Product Type
      • 17.6.3. Technology
      • 17.6.4. Sample Type
      • 17.6.5. Application
      • 17.6.6. End User
      • 17.6.7. Distribution Channel
    • 17.7. Algeria Point-of-Care Diagnostics Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Product Type
      • 17.7.3. Technology
      • 17.7.4. Sample Type
      • 17.7.5. Application
      • 17.7.6. End User
      • 17.7.7. Distribution Channel
    • 17.8. Rest of Africa Point-of-Care Diagnostics Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Product Type
      • 17.8.3. Technology
      • 17.8.4. Sample Type
      • 17.8.5. Application
      • 17.8.6. End User
      • 17.8.7. Distribution Channel
  • 18. South America Point-of-Care Diagnostics Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. South America Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Product Type
      • 18.3.2. Technology
      • 18.3.3. Sample Type
      • 18.3.4. Application
      • 18.3.5. End User
      • 18.3.6. Distribution Channel
      • 18.3.7. Country
        • 18.3.7.1. Brazil
        • 18.3.7.2. Argentina
        • 18.3.7.3. Rest of South America
    • 18.4. Brazil Point-of-Care Diagnostics Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Product Type
      • 18.4.3. Technology
      • 18.4.4. Sample Type
      • 18.4.5. Application
      • 18.4.6. End User
      • 18.4.7. Distribution Channel
    • 18.5. Argentina Point-of-Care Diagnostics Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Product Type
      • 18.5.3. Technology
      • 18.5.4. Sample Type
      • 18.5.5. Application
      • 18.5.6. End User
      • 18.5.7. Distribution Channel
    • 18.6. Rest of South America Point-of-Care Diagnostics Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Product Type
      • 18.6.3. Technology
      • 18.6.4. Sample Type
      • 18.6.5. Application
      • 18.6.6. End User
      • 18.6.7. Distribution Channel
  • 19. Key Players/ Company Profile
    • 19.1. Abbott Laboratories
      • 19.1.1. Company Details/ Overview
      • 19.1.2. Company Financials
      • 19.1.3. Key Customers and Competitors
      • 19.1.4. Business/ Industry Portfolio
      • 19.1.5. Product Portfolio/ Specification Details
      • 19.1.6. Pricing Data
      • 19.1.7. Strategic Overview
      • 19.1.8. Recent Developments
    • 19.2. Becton, Dickinson and Company
    • 19.3. bioMérieux S.A.
    • 19.4. Bio-Rad Laboratories, Inc.
    • 19.5. Chembio Diagnostics, Inc.
    • 19.6. Danaher Corporation
    • 19.7. EKF Diagnostics Holdings plc
    • 19.8. F. Hoffmann-La Roche Ltd.
    • 19.9. Nova Biomedical Corporation
    • 19.10. OraSure Technologies, Inc.
    • 19.11. PTS Diagnostics
    • 19.12. QIAGEN N.V.
    • 19.13. QuidelOrtho Corporation
    • 19.14. Sekisui Diagnostics, LLC
    • 19.15. Siemens Healthineers AG
    • 19.16. Sysmex Corporation
    • 19.17. Thermo Fisher Scientific Inc.
    • 19.18. Trinity Biotech plc
    • 19.19. Trividia Health, Inc.
    • 19.20. Werfen S.A.
    • 19.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation